The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2466
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
The dietary antioxidant quercetin reduces hallmarks of bleomycin-induced lung fibrogenesis in mice ; volume:20 ; number:1 ; day:29 ; month:4 ; year:2020 ; pages:1-16 ; date:12.2020
BMC pulmonary medicine ; 20, Heft 1 (29.4.2020), 1-16, 12.2020

Urheber
Boots, Agnes W.
Veith, Carmen
Albrecht, Catrin
Bartholome, Roger
Drittij, Marie-José
Claessen, Sandra M. H.
Bast, Aalt
Rosenbruch, Martin
Jonkers, Leonie
Schooten, Frederik-Jan van
Schins, Roel P. F.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12890-020-1142-x
URN
urn:nbn:de:101:1-2020070800234198140177
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:02 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Boots, Agnes W.
  • Veith, Carmen
  • Albrecht, Catrin
  • Bartholome, Roger
  • Drittij, Marie-José
  • Claessen, Sandra M. H.
  • Bast, Aalt
  • Rosenbruch, Martin
  • Jonkers, Leonie
  • Schooten, Frederik-Jan van
  • Schins, Roel P. F.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Plumbagin attenuates Bleomycin-induced lung fibrosis in mice

Plumbagin attenuates Bleomycin-induced lung fibrosis in mice

Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis

Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ

Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ

A critical role of AREG for bleomycin-induced skin fibrosis

A critical role of AREG for bleomycin-induced skin fibrosis

Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy

Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy

Bleomycin-induced genome structural variations in normal, non-tumor cells

Bleomycin-induced genome structural variations in normal, non-tumor cells

Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice

Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice

Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis

Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis

Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis

Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

Gut microbiota modulates bleomycin-induced acute lung injury response in mice

Gut microbiota modulates bleomycin-induced acute lung injury response in mice

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis

Verbundene Objekte